New research has found that a common antibiotic may increase the risk of pregnancy loss.
A new study analysing over 200,000 pregnancies has found that taking doxycycline – a common antibiotic used for severe acne and respiratory infections – during the first trimester may increase the risk of early pregnancy loss.
Experts say high rates of unplanned pregnancies mean many women are inadvertently taking it before they know they are expecting.
“It is generally avoided in pregnancy, particularly from the second trimester, due to known adverse effects on fetal bone and tooth development,” University of the Sunshine Coast senior lecturer Dr Linda Gallo says.
“However, considering that approximately 40 per cent of pregnancies in Australia are unplanned, doxycycline exposure in early pregnancy occurs.”
So, should women be concerned? Australian experts explain the known risks around doxycycline and what this US research means.
What is doxycycline?
“Doxycycline is a common type of antibiotic for treating conditions such as acne and respiratory tract infections,” Dr Gallo explains.
She says it’s a common treatment option for severe acne when topical options aren’t effective.
“Doxycycline has been associated with DNA damage in animal embryos and may interfere with biological processes essential for early placental development,” gynaecologist and professor of reproductive medicine at Flinders University Kelton Tremellen says.
However, Dr Gallo says exposure can occur in the first trimester, where a woman might be taking doxycycline to manage a health condition and not yet know she is pregnant.
What the research found
This study was led by researchers from the University of Florida, who analysed insurance claims data from over 200,000 pregnant women to compare the outcomes of women who took doxycycline in early pregnancies, to women who received alternative treatments.
The findings suggest that exposure to doxycycline during the first trimester can increase the risk of pregnancy loss.
“In women prescribed doxycycline for a respiratory tract infection, the risk of pregnancy loss was greater than in those prescribed amoxycillin or macrolides,” Dr Gallo explains.
“For acne, the results were mixed as one database showed a higher risk with doxycycline, but the other did not.”
What do these findings mean?
“The key message is that doctors should consider avoiding doxycycline in women of childbearing age who are not using reliable contraception, where suitable alternatives are available,” Prof Tremellen says.
The study did have some drawbacks, which experts say could be clarified in future research.
“A key limitation of the study is that it only examined pregnancy loss,” Adelaide University professor Janna Morrison, deputy director for health and biomedical innovation, says.
“More research is needed to understand whether antibiotics increase the risk of early pregnancy loss or affect the longer-term health of babies.”
Prof Morrison agrees with Prof Tremellen, however, and says these findings “may help doctors make more informed decisions about which antibiotics to prescribe to pregnant women who require treatment for conditions such as respiratory infections or acne”.